The protective effect of vanadium against diabetic cataracts in diabetic rat model

Biological Trace Element Research

Volumn 158, Issue 2, 2014, Pages 219-223

  Sun, Lei ^a   Shi, De Jing ^a   Gao, Xiang Chun ^a   Mi, Shu Yong ^a   Yu, Ying ^a   Han, Qing ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Blood glucose; Cataract; Diabetes; Vanadium

Indexed keywords

ALDEHYDE REDUCTASE; CARBONYL DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MALONALDEHYDE; SORBITOL; SUPEROXIDE DISMUTASE; VANADATE SODIUM; ALLOXAN; VANADIUM;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CAPSULE OPACIFICATION; CATARACT; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC CATARACT; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; EYE PROTECTION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN CONTENT; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODEL; HYPERGLYCEMIA; OXIDATIVE STRESS; PATHOLOGY; WISTAR RAT;

RATTUS;

ALLOXAN; ANIMALS; CATARACT; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; HYPERGLYCEMIA; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; VANADIUM;

EID: 84899649647     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-9925-7     Document Type: Article

References (19)

1. PollreiszA, Schmidt-ErfurthU (2010) Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol 2010:608751
2. Kyselova Z, Stefek M, Bauer V (2004) Pharmacological prevention of diabetic cataract. J Diabet Complicat 18:129-140 (Pubitemid 38559078)
3. Nakamura J, Kasuya Y, Hamada Y et al (2001) Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity. Diabetologia 44:480-487 (Pubitemid 32324359)
4. Chung SS, Chung SK (2003) Genetic analysis of aldose reductase in diabetic complications. Curr Med Chem 10:1375-1387 (Pubitemid 36903154)
5. Banditelli S, Boldrini E, Vilardo PG et al (1999) A new approach against sugar cataract through aldose reductase inhibitors. Exp Eye Res 69:533-538
6. Klein BEK, Klein R, Wang Q et al (1995) Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalmic Epidemiol 2:49-55
7. Klein BEK, Klein R, Lee KE (1998) Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol 126:782-90 (Pubitemid 29001627)
8. Shindea UA, Sharma G, Xu YJ et al (2004) Insulin sensitising action of chromium picolinate in various experimental models of diabetes mellitus. J Trace Elem Med Biol 18:23-32 (Pubitemid 39285961)
9. Nomura Y, Okamoto S, Sakamoto M et al (2005) Effect of cobalt on the liver glycogen content in the streptozotocin-induced diabetic rats. Mol Cell Biochem 277:127-130 (Pubitemid 41236194)
10. Gil J, MiralpeixM, Carreras J, Bartrons R (1988) Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats. J Biol Chem 263:1868-1871 (Pubitemid 18052142)
11. Shechter Y (1990) Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes 39:1-5
12. Lu B, Ennis D, Lai R, Bogdanovic E (2001) Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4). J Biol Chem 276:35589-35598
13. Preet A, Gupta B, Yadava PK et al (2005) Efficacy of lower doses of vanadium in restoring altered glucose metabolism and antioxidant status in diabetic rat lenses. J Biosci 30(2):221-230 (Pubitemid 40598071)
14. Reddy PY, Giridharan NV, Reddy GB (2012) Activation of sorbitol pathway in metabolic syndrome and increased susceptibility to cataract in Wistar-Obese rats. Mol Vis 18:495-503
15. Pollreisz A, Schmidt-Erfurth U (2010) Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol. doi:10.1155/2010/608751, ID 608751
16. Obrosova IG, Chung SSM, Kador PF (2010) Diabetic cataracts: mechanisms and management. DiabetesMetab Res Rev 26:172-180
17. Vats V, Yadav SP, Biswas NR et al (2004) Anti-cataract activity of Pterocarpus marsupium bark and Trigonella foenum-graecum seeds extract in alloxan diabetic rats. J Ethnopharmacol 93:289-294 (Pubitemid 38962419)
18. Zhang S, Chai FY, Yan H et al (2008) Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract in rats. Mol Vis 14:862-870 (Pubitemid 351715814)
19. Srivastava SK, Ramana KV, Bhatnagar A (2005) Role of aldose and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 26:380-392 (Pubitemid 40691299)